Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $39.00

Key Points

• Cantor Fitzgerald raised Acadia Healthcare’s price target from $30 to $39 while maintaining a neutral rating, implying 12.1% upside from the previous close.
• Analyst opinions remain mixed: MarketBeat reports a consensus “Hold” rating and an average price target of $31.62, despite several firms assigning Buy ratings.
• Acadia beat quarterly estimates, reporting EPS of $0.60 versus $0.46 expected and revenue of $895.3 million versus $877.8 million expected; revenue grew 5.1% year over year, though EPS was down from $0.72 a year earlier.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price target hoisted by research analysts at Cantor Fitzgerald from $30.00 to $39.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a "neutral" rating on the stock. Cantor Fitzgerald's price target indicates a potential upside of 12.10% from the stock's previous close.

Several other analysts have also issued reports on ACHC. TD Cowen increased their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Guggenheim raised their target price on Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Barclays lifted their price target on Acadia Healthcare from $32.00 to $35.00 and gave the company an "equal weight" rating in a research note on Thursday. KeyCorp boosted their price target on Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a report on Tuesday, July 14th. Finally, Leerink Partners upped their price objective on Acadia Healthcare from $30.00 to $33.00 and gave the stock a "market perform" rating in a research report on Wednesday, September 23rd. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $31.62.

Acadia Healthcare Trading Up 7.9%

NASDAQ ACHC opened at $34.79 on Friday. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $39.38. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock has a 50 day moving average of $29.27 and a 200-day moving average of $26.03. The company has a market cap of $3.24 billion, a PE ratio of -2.79, a PEG ratio of 10.39 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.14. The business had revenue of $895.31 million during the quarter, compared to the consensus estimate of $877.76 million. Acadia Healthcare had a positive return on equity of 6.58% and a negative net margin of 33.07%. The company's quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.72 EPS. On average, equities research analysts anticipate that Acadia Healthcare will post 1.55 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in ACHC. Fifth Third Bancorp grew its position in shares of Acadia Healthcare by 62.9% during the third quarter. Fifth Third Bancorp now owns 184,629 shares of the company's stock worth $5,077,000 after purchasing an additional 71,304 shares in the last quarter. Maryland State Retirement & Pension System raised its position in shares of Acadia Healthcare by 54.8% during the third quarter. Maryland State Retirement & Pension System now owns 20,674 shares of the company's stock valued at $569,000 after buying an additional 7,316 shares during the last quarter. Jefferies Financial Group Inc. raised its position in shares of Acadia Healthcare by 2.7% during the third quarter. Jefferies Financial Group Inc. now owns 3,703,240 shares of the company's stock valued at $101,839,000 after buying an additional 98,173 shares during the last quarter. Penn Capital Management Company LLC purchased a new position in shares of Acadia Healthcare in the third quarter worth $15,434,000. Finally, Prescott Group Capital Management L.L.C. lifted its holdings in shares of Acadia Healthcare by 40.0% in the third quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company's stock worth $1,925,000 after buying an additional 20,000 shares in the last quarter.

Trending Headlines about Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.60 per share, beating the $0.46 consensus estimate, while revenue of $895.3 million exceeded forecasts of $877.8 million and grew 5.1% year over year. Same-facility revenue rose 5.2%, supported by higher patient days and revenue per patient day. Acadia Healthcare Q3 results and guidance
• Positive Sentiment: Acadia raised its full-year 2026 financial guidance. The earnings-call coverage also pointed to stronger growth ahead, reinforcing the outlook beyond the quarterly beat. Earnings call growth outlook
• Neutral Sentiment: Barclays raised its price target from $32 to $35 but kept an “equal weight” rating, indicating a more measured view of further upside. Barclays price target
• Negative Sentiment: Despite beating estimates, quarterly EPS declined from $0.72 in the year-ago period to $0.60, a year-over-year earnings headwind.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia's services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.